Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2γ transcription factor

被引:140
作者
Aqeilan, RI
Palamarchuk, A
Weigel, RJ
Herrero, JJ
Pekarsky, Y
Croce, CM
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA
[2] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA USA
[3] Axcell Biosci Corp, Newtown, PE, Canada
关键词
D O I
10.1158/0008-5472.CAN-04-2055
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The WWOX gene encodes a tumor suppressor WW domain-containing protein, Wwox. Alterations of WWOX have been demonstrated in multiple types of cancer, and introduction of Wwox into Wwox-negative tumor cells has resulted in tumor suppression and apoptosis. The Wwox protein contains two WW domains that typically bind proline-rich motifs and mediate protein-protein interactions. Recently, we have described functional cross-talk between the Wwox protein and the p53 homologue, p73. To further explore the biological function of Wwox, we investigated other interacting candidates. In this report, we demonstrate a physical and functional association between AP-2gamma transcription factor and the Wwox protein. AP-2gamma at 20q13.2 encodes a transcription factor and is frequently amplified in breast carcinoma. We show that Wwox binds to the PPPY motif of AP-2gamma via its first WW domain. Alterations of tyrosine 33 in the first WW domain of Wwox or the proline-rich motif in AP-2gamma dramatically reduce this interaction. In addition, our results demonstrate that Wwox expression triggers redistribution of nuclear AP-2gamma to the cytoplasm, hence suppressing its transactivating function. Our results suggest that Wwox tumor suppressor protein inhibits AP-2gamma oncogenic activity by sequestering it in the cytoplasm.
引用
收藏
页码:8256 / 8261
页数:6
相关论文
共 39 条
[1]   Functional association between Wwox tumor suppressor protein and p73, a p53 homolog [J].
Aqeilan, RI ;
Pekarsky, Y ;
Herrero, JJ ;
Palamarchuk, A ;
Letofsky, J ;
Druck, T ;
Trapasso, F ;
Han, SY ;
Melino, G ;
Huebner, K ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (13) :4401-4406
[2]   Loss of WWOX expression in gastric carcinoma [J].
Aqeilan, RI ;
Kuroki, T ;
Pekarsky, Y ;
Albagha, O ;
Trapasso, F ;
Baffa, R ;
Huebner, K ;
Edmonds, P ;
Croce, CM .
CLINICAL CANCER RESEARCH, 2004, 10 (09) :3053-3058
[3]  
Bednarek AK, 2000, CANCER RES, V60, P2140
[4]  
Bednarek AK, 2001, CANCER RES, V61, P8068
[5]   THE DEVELOPMENTALLY-REGULATED TRANSCRIPTION FACTOR AP-2 IS INVOLVED IN C-ERBB-2 OVEREXPRESSION IN HUMAN MAMMARY-CARCINOMA [J].
BOSHER, JM ;
WILLIAMS, T ;
HURST, HC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :744-747
[6]  
Bosher JM, 1996, ONCOGENE, V13, P1701
[7]   JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis [J].
Chang, NS ;
Doherty, J ;
Ensign, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9195-9202
[8]   Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity [J].
Chang, NS ;
Pratt, N ;
Heath, J ;
Schultz, L ;
Sleve, D ;
Carey, GB ;
Zevotek, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) :3361-3370
[9]  
DECONINCK EC, 1995, MOL CELL BIOL, V15, P2191
[10]   Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors [J].
Driouch, K ;
Prydz, H ;
Monese, R ;
Johansen, H ;
Lidereau, R ;
Frengen, E .
ONCOGENE, 2002, 21 (12) :1832-1840